Screening and Evaluation of Neurodevelopmental Impairments in Infants Under 6 Months of Age with Congenital Heart Disease
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Cardiology"
DOI: 10.1007/s00246-021-02745-4
Abstract: Clinical evaluation of neurodevelopmental impairments before 6 months of age is needed in congenital heart disease (CHD) to promote early referral to developmental interventions. The objective was to identify the risk of cerebral palsy (CP)… read more here.
Keywords: age; months age; neurodevelopmental impairments; physiology ... See more keywords